Mirae Asset Global ETFs Holdings
SMMT icon

Mirae Asset Global ETFs Holdings’s Summit Therapeutics SMMT Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$344K Buy
24,002
+5,645
+31% +$100K ﹤0.01% 2201
2026
Q1 		$312K Buy
18,357
+1,497
+9% +$24.2K ﹤0.01% 2126
2025
Q4 		$295K Sell
16,860
-1,136
-6% -$21.4K ﹤0.01% 2163
2025
Q3 		$380K Buy
17,996
+7,685
+75% +$186K ﹤0.01% 2003
2025
Q2 		$213K Sell
10,311
-55,100
-84% -$1.26M ﹤0.01% 2251
2025
Q1 		$1.27M Buy
65,411
+694
+1% +$13.9K ﹤0.01% 1375
2024
Q4 		$1.16M Buy
64,717
+12,546
+24% +$243K ﹤0.01% 1476
2024
Q3 		$1.14M Sell
52,171
-12,647
-20% -$177K ﹤0.01% 1466
2024
Q2 		$506K Buy
+64,818
New +$350K ﹤0.01% 1820

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's SMMT Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Summit Therapeutics (SMMT) stake by 31% in Q2 2026, buying an estimated $100K and bringing the position to 24,002 shares worth $344K. The position accounts for ﹤0.01% of the portfolio, ranked #2201.

Mirae Asset Global ETFs Holdings first reported a position in SMMT in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.27M in Q1 2025. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 24,002 shares of Summit Therapeutics worth $344K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 5,645 Summit Therapeutics shares in Q2 2026, an estimated $100K.
  • Summit Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2201 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Summit Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Summit Therapeutics position peaked at $1.27M in Q1 2025.
  • 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.